These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8910855)

  • 1. Involvement of a cytochrome P450 system in microsomal debromination of alpha-(bromisovaleryl)urea.
    Oka K; Kitamura S; Tatsumi K
    J Pharm Pharmacol; 1996 Sep; 48(9):930-2. PubMed ID: 8910855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
    Zbaida S; Levine WG
    Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver.
    Walton MI; Wolf CR; Workman P
    Biochem Pharmacol; 1992 Jul; 44(2):251-9. PubMed ID: 1642640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
    Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
    Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cimetidine with cytochrome P450 and effect on mixed-function oxidase activities of liver microsomes.
    Faux SP; Combes RD
    Hum Exp Toxicol; 1993 Mar; 12(2):147-52. PubMed ID: 8096713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
    Nebbia C; Ceppa L; Dacasto M; Carletti M
    J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the antioxidant capacities of some benzimidazoles in rat tissues.
    Can-Eke B; Puskullu MO; Buyukbingol E; Iscan M
    Chem Biol Interact; 1998 May; 113(1):65-77. PubMed ID: 9630848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
    Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
    Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes.
    Nomura A; Sakurai E; Hikichi N
    J Pharm Pharmacol; 1997 Mar; 49(3):257-62. PubMed ID: 9231341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins.
    Day BJ; Kariya C
    Toxicol Sci; 2005 May; 85(1):713-9. PubMed ID: 15703263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnenolone-16alpha-carbonitrile-inducible cytochrome P450 in rat liver.
    Birnbaum LS; Baird MB; Massie HR
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):553-62. PubMed ID: 825936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
    Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochrome P4501A in biotransformation of the potential anticancer drug oracin.
    Szotáková B; Wsól V; Skálová L; Kvasnicková E
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):428-31. PubMed ID: 10445410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-ionone on the expression of cytochrome P450s and NADPH-cytochrome P450 reductase in Sprague Dawley rats.
    Jeong TC; Gu HK; Chun YJ; Yun CH; Han SS; Roh JK
    Chem Biol Interact; 1998 Jul; 114(1-2):97-107. PubMed ID: 9744558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron-transport cytochrome P-450 system is involved in the microsomal metabolism of the carcinogen chromate.
    Garcia JD; Jennette KW
    J Inorg Biochem; 1981 Jul; 14(4):281-95. PubMed ID: 6792322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs.
    Graham RA; Downey A; Mudra D; Krueger L; Carroll K; Chengelis C; Madan A; Parkinson A
    Drug Metab Dispos; 2002 Nov; 30(11):1206-13. PubMed ID: 12386126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
    Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
    Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.